Product Name :
Human LILRB1 Protein
EN
ILT2; ILT-2; ILT2FLJ37515; LILRB1; LIR1; MIR7; CD85J; XXbac-BCX85G21.4
Description:
| Human LILRB1/CD85j/ILT2 Protein with the C-His Tag |Source: The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The recombinant Human LILRB1/CD85j/ILT2 Protein is shipped with ice |Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 week, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Source:
The recombinant Human LILRB1/CD85j/ILT2 Protein, (amino acids Leu116-Val461) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight :
The recombinant Human LILRB1/CD85j/ILT2 protein with the His tag at the C-terminus has a predicted MW of 38.15 kDa. Due to glycosylation, the protein migrates to 55-68 kDa based on Tris-Bis PAGE result.
Activity:
Purity :
>95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin:
LevelLess than 1 EU per ug of protein as determined by LAL method.
Formulation :
Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution:
It is recommended to reconstitute the lyophilized recombinant Human LILRB1/CD85j/ILT2 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening. BP005549Human LILRB1/CD85j/ILT2 Protein with the C-hFc Tag SourceThe recombinant Human LILRB1/CD85j/ILT2 Protein, (amino acids Gly24-Arg457) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Shipping:
The recombinant Human LILRB1/CD85j/ILT2 Protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage :
/strong>Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
IL-36 alpha /IL-1 F6 ProteinFormulation
Granzyme D/GZMD ProteinBiological Activity
Popular categories:
CD119
Complement Receptor 3